Newsroom | 27490 results
Sorted by: Latest
-
Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell to Release Second Quarter 2026 Financial Results on July 30, 2026...
-
MindWalk Holdings Corp. publiera ses résultats financiers et les faits marquants de son activité pour le quatrième trimestre et l'ensemble de l'exercice 2026 le 22 juillet 2026
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (« MindWalk » ou la « Société ») (NASDAQ : HYFT), une entreprise spécialisée dans l’IA bio-native, a annoncé aujourd’hui qu’elle publierait ses résultats financiers pour le quatrième trimestre et l’ensemble de l’exercice 2026, et qu’elle tiendrait une conférence téléphonique le mercredi 22 juillet 2026, à 17 h, heure de l’Est. Les résultats financiers seront publiés dans un communiqué de presse avant la conférence téléphonique, qui compren...
-
Corner Health Announces $32.5 Million in Seed and Series A Financing to Help Independent Clinicians Rebuild Primary Care
LOS ANGELES--(BUSINESS WIRE)--Corner Health, a company designed to rebuild the healthcare system by empowering Nurse Practitioners (NPs) to start and scale their own local primary care practices, announced today it has raised $32.5 million in Seed and Series A financing. Their recent Series A was led by Oak HC/FT, with participation from existing investors First Round Capital and Zigg Capital. The investment follows a period of rapid growth for Corner Health, which has established a network of...
-
Massive Bio Announces Partnership with Sequence Me Now to Help Cancer Patients Access Clinical Trials
BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio, a technology company that uses artificial intelligence to help cancer patients identify clinical trials for which they may be eligible, today announced a new partnership with Sequence Me Now (SMN), a nonprofit patient advocacy organization dedicated to helping cancer patients access genomic sequencing and personalized medicine. Through the partnership, Massive Bio is featured on the "Find a Trial" page of Sequence Me Now's website, the fourth step...
-
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: HYFT), a Bio-Native AI company, today announced that it will report financial results for the fourth quarter and full fiscal year 2026 and host a conference call on Wednesday, July 22, 2026, at 5:00 p.m. Eastern Time. Financial results will be issued in a press release prior to the call, which will include a management presentation followed by a question-and-answer session. Conference Call and Webcast...
-
Machinify Adds Genetic Testing Expertise to Its Comprehensive Payment Intelligence Platform
DALLAS & PALO ALTO, Calif.--(BUSINESS WIRE)--Machinify today announced a new genetic testing capability, extending the platform’s intelligence into one of healthcare’s fastest-growing and most clinically complex specialties. The expansion represents another step in applying Machinify’s AI to increasingly sophisticated healthcare payment decisions, helping health plans address areas that have outpaced traditional payment integrity approaches. Genetic testing represents one of the fastest-growing...
-
Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. will release its second quarter 2026 financial results on Thursday, August 6, 2026....
-
Physicians Across Retina Consultants of America Network to Present Key Trial Data and Clinical Insights at ASRS 2026
SOUTHLAKE, Texas--(BUSINESS WIRE)--Retina specialists across the Retina Consultants of America (RCA) network will present clinical trial data, real-world evidence, surgical techniques, and novel treatment approaches across more than 30 sessions at the American Society of Retina Specialists (ASRS) 44th Annual Meeting, July 15-18. The research features late-breaking abstracts and clinical trial data, including data from a gene therapy for neovascular age-related macular degeneration (AMD), a comp...
-
CareXM and OnePoint Patient Care Partner to Get Medications to Hospice Patients Faster After Hours
WEST JORDAN, Utah--(BUSINESS WIRE)--CareXM and OnePoint announce a partnership to reduce delays when medication needs arise after hours for hospice patients....
-
Chai Discovery Announces Collaboration with Novartis to Advance AI-Driven Antibody Discovery
SAN FRANCISCO--(BUSINESS WIRE)--Chai Discovery announces collaboration with Novartis to advance AI-driven antibody discovery...